{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:25:38Z","timestamp":1778883938564,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,7,23]],"date-time":"2014-07-23T00:00:00Z","timestamp":1406073600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Neurovirol."],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s13365-014-0268-0","type":"journal-article","created":{"date-parts":[[2014,7,22]],"date-time":"2014-07-22T13:30:33Z","timestamp":1406035833000},"page":"645-652","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["JC virus urinary excretion and seroprevalence in natalizumab-treated multiple sclerosis patients"],"prefix":"10.1007","volume":"21","author":[{"given":"Serena","family":"Delbue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Elia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilla","family":"Carloni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Pecchenini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Franciotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Gastaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Signorini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Carluccio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Bellizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Bergamaschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pasquale","family":"Ferrante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,7,23]]},"reference":[{"key":"268_CR1","first-page":"495","volume":"12","author":"JR Berger","year":"2012","unstructured":"Berger JR, Khalili K (2012) The pathogenesis of progressive multifocal leukoencephalopathy. Discov Med 12:495\u2013503","journal-title":"Discov Med"},{"key":"268_CR2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/ana.23893","volume":"74","author":"JR Berger","year":"2013","unstructured":"Berger JR, Houff SA, Gurwell J, Vega N, Miller CS, Danaher RJ (2013) JC virus antibody status underestimates infection rates. Ann Neurol 74:84\u201390","journal-title":"Ann Neurol"},{"key":"268_CR3","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJMoa1107829","volume":"366","author":"G Bloomgren","year":"2012","unstructured":"Bloomgren G, Richman S, Hotermans C, Subramanyam M, Goelz S, Natarajan A, Lee S, Plavina T, Scanlon JV, Sandrock A, Bozic C (2012) Risk of natalizumab-associated progressive multifocal leukoencephalopathy. N Engl J Med 366:1870\u20131880","journal-title":"N Engl J Med"},{"key":"268_CR4","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1056\/NEJMoa0904267","volume":"361","author":"Y Chen","year":"2009","unstructured":"Chen Y, Bord E, Tompkins T, Miller J, Tan CS, Kinkel RP, Stein MC, Viscidi RP, Ngo LH, Koralnik IJ (2009) Asymptomatic reactivation of JC virus in patients treated with natalizumab. N Engl J Med 361:1067\u20131074","journal-title":"N Engl J Med"},{"key":"268_CR5","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S1474-4422(10)70028-4","volume":"9","author":"DB Clifford","year":"2010","unstructured":"Clifford DB, De Luca A, Simpson DM, Arendt G, Giovannoni G, Nath A (2010) Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases. Lancet Neurol 9:438\u2013446","journal-title":"Lancet Neurol"},{"key":"268_CR6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/13550280590900382","volume":"11","author":"S Delbue","year":"2005","unstructured":"Delbue S, Sotgiu G, Fumagalli D, Valli M, Borghi E, Mancuso R, Marchioni E, Maserati R, Ferrante P (2005) A case of a PML patient with four different JC virus TCR rearrangements in CSF, blood, serum and urine. J Neurovirol 11:51\u201357","journal-title":"J Neurovirol"},{"key":"268_CR7","first-page":"77","volume":"13","author":"S Delbue","year":"2007","unstructured":"Delbue S, Guerini F, Mancuso R, Caputo D, Mazziotti R, Saresella M, Ferrante P (2007) JCV viremia in interferon-beta treated and untreated Italian multiple sclerosis patients and healthy controls. J Neurovirol 13:77\u201378","journal-title":"J Neurovirol"},{"key":"268_CR8","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1136\/jnnp-2012-304777","volume":"84","author":"T Derfuss","year":"2013","unstructured":"Derfuss T, Kappos L (2013) Predicting PML in natalizumab-treated patients: can we do better? J Neurol Neurosurg Psychiatry 84:1182\u20131183","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"268_CR9","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s11481-013-9496-y","volume":"8","author":"MI Dominguez-Mozo","year":"2013","unstructured":"Dominguez-Mozo MI, Garcia-Montojo M, De Las HV et al (2013) Anti-JCV antibodies detection and JCV DNA levels in PBMC, serum and urine in a cohort of Spanish multiple sclerosis patients treated with natalizumab. J NeuroImmune Pharm 8:1277\u201386","journal-title":"J NeuroImmune Pharm"},{"key":"268_CR10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1006\/viro.1994.1008","volume":"198","author":"K D\u00f6rries","year":"1994","unstructured":"D\u00f6rries K, Vogel E, G\u00fcnther S, Czub S (1994) Infection of human polyomaviruses JC and BK in peripheral blood leukocytes from immunocompetent individuals. Virology 198:59\u201370","journal-title":"Virology"},{"key":"268_CR11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/(SICI)1096-9071(199707)52:3<235::AID-JMV1>3.0.CO;2-3","volume":"52","author":"P Ferrante","year":"1997","unstructured":"Ferrante P, Caldarelli-Stefano R, Omodeo-Zorini E, Mediati M, Fainardi E, Granieri E, Caputo D (1997) Comprehensive investigation of the presence of JC virus in AIDS patients with and without progressive multifocal leukoencephalopathy. J Med Virol 52:235\u2013242","journal-title":"J Med Virol"},{"key":"268_CR12","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ana.22128","volume":"68","author":"L Gorelik","year":"2010","unstructured":"Gorelik L, Lerner M, Bixler S, Crossman M, Schlain B, Simon K, Pace A, Cheung A, Chen LL, Berman M, Zein F, Wilson E, Yednock T, Sandrock A, Goelz SE, Subramanyam M (2010) Anti-JC virus antibodies: implications for PML risk stratification. Ann Neurol 68:295\u2013303","journal-title":"Ann Neurol"},{"key":"268_CR13","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S1474-4422(10)70006-5","volume":"9","author":"S Jilek","year":"2010","unstructured":"Jilek S, Jaquiery E, Hirsch HH, Lysandropoulos A, Canales M, Guignard L, Schluep M, Pantaleo G, Du Pasquier RA (2010) Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study. Lancet Neurol 9:264\u201372","journal-title":"Lancet Neurol"},{"key":"268_CR14","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S1474-4422(11)70149-1","volume":"10","author":"L Kappos","year":"2011","unstructured":"Kappos L, Bates D, Edan G, Eraksoy M, Garcia-Merino A, Grigoriadis N, Hartung HP, Havrdov\u00e1 E, Hillert J, Hohlfeld R, Kremenchutzky M, Lyon-Caen O, Miller A, Pozzilli C, Ravnborg M, Saida T, Sindic C, Vass K, Clifford DB, Hauser S, Major EO, O'Connor PW, Weiner HL, Clanet M, Gold R, Hirsch HH, Rad\u00fc EW, S\u00f8rensen PS, King J (2011) Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring. Lancet Neurol 10:745\u2013758","journal-title":"Lancet Neurol"},{"key":"268_CR15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/jmv.10450","volume":"71","author":"WA Knowles","year":"2003","unstructured":"Knowles WA, Pipkin P, Andrews N, Vyse A, Minor P, Brown DW, Miller E (2003) Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol 71:115\u2013123","journal-title":"J Med Virol"},{"key":"268_CR16","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s11481-012-9366-z","volume":"7","author":"A Laroni","year":"2012","unstructured":"Laroni A, Giacomazzi CG, Grimaldi L, Gallo P, Sormani MP, Bertolotto A, McDermott JL, Gandoglia I, Martini I, Vitello G, Rinaldi F, Barzon L, Militello V, Pizzorno M, Bandini F, Capello E, Pal\u00f9 G, Uccelli A, Mancardi GL, Varnier OE (2012) Urinary JCV-DNA testing during natalizumab treatment may increase accuracy of PML risk stratification. J NeuroImmune Pharm 7:665\u2013672","journal-title":"J. NeuroImmune Pharm"},{"key":"268_CR17","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jcv.2013.02.002","volume":"57","author":"P Lee","year":"2013","unstructured":"Lee P, Plavina T, Castro A, Berman M, Jaiswal D, Rivas S, Schlain B, Subramanyam M (2013) A second-generation ELISA (STRATIFY JCV DxSelect) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification. J Clin Virol 57:141\u2013146","journal-title":"J Clin Virol"},{"key":"268_CR18","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3109\/13550280903131923","volume":"15","author":"R Lonergan","year":"2009","unstructured":"Lonergan R, Carr M, De Gascun C, Costelloe LF, Waters A, Coughlan S, Duggan M, Doyle K, Jordan S, Hutchinson MW, Hall WW, Tubridy NJ (2009) Reactivation of BK polyomavirus in patients with multiple sclerosis receiving natalizumab therapy. J Neurovirol 15:351\u2013359","journal-title":"J Neurovirol"},{"key":"268_CR19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1146\/annurev.med.080708.082655","volume":"61","author":"EO Major","year":"2010","unstructured":"Major EO (2010) Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies. Annu Rev Med 61:35\u201347","journal-title":"Annu Rev Med"},{"key":"268_CR20","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1056\/NEJMc1214233","volume":"368","author":"EO Major","year":"2013","unstructured":"Major EO, Frohman E, Douek D (2013a) JC viremia in natalizumab-treated patients with multiple sclerosis. N Engl J Med 368:2240\u20132241","journal-title":"N Engl J Med"},{"key":"268_CR21","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMc1308784","volume":"369","author":"EO Major","year":"2013","unstructured":"Major EO, Frohman E, Douek D (2013b) More on JC viremia in natalizumab-treated patients with multiple sclerosis. N Engl J Med 369:1279\u201380","journal-title":"N Engl J Med"},{"key":"268_CR22","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/1479-5876-10-248","volume":"10","author":"R Mancuso","year":"2012","unstructured":"Mancuso R, Saresella M, Hernis A, Marventano I, Ricci C, Agostini S, Rovaris M, Caputo D, Clerici M (2012) JC virus detection and JC virus-specific immunity in natalizumab-treated multiple sclerosis patients. J Transl Med 10:248\u2013250","journal-title":"J Transl Med"},{"key":"268_CR23","first-page":"199","volume":"28","author":"V Pietropaolo","year":"2005","unstructured":"Pietropaolo V, Fioriti D, Mischitelli M, Anzivino E, Santini M, Millefiorini E, Di Rezze S, Degener AM (2005) Detection of human herpesviruses and polyomaviruses DNA in a group of patients with relapsing-remitting multiple sclerosis. New Microbiol 28:199\u2013203","journal-title":"New Microbiol"},{"key":"268_CR24","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1056\/NEJMoa044397","volume":"354","author":"CH Polman","year":"2006","unstructured":"Polman CH, O'Connor PW, Havrdova E, Hutchinson M, Kappos L, Miller DH, Phillips JT, Lublin FD, Giovannoni G, Wajgt A, Toal M, Lynn F, Panzara MA, Sandrock AW, Investigators AFFIRM (2006) A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 354:899","journal-title":"N Engl J Med"},{"key":"268_CR25","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1136\/jnnp.2009.201079","volume":"81","author":"L Rinaldi","year":"2010","unstructured":"Rinaldi L, Rinaldi F, Perini P, Calabrese M, Seppi D, Grossi P, Mattisi I, Barzon L, Mengoli C, Sanzari M, Pal\u00fa G, Gallo P (2010) No evidence of JC virus reactivation in natalizumab treated multiple sclerosis patients: an 18\u00a0month follow-up study. J Neurol Neurosurg Psychiatry 81:1345\u20131350","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"268_CR26","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa044396","volume":"354","author":"RA Rudick","year":"2006","unstructured":"Rudick RA, Stuart WH, Calabresi PA, Confavreux C, Galetta SL, Radue EW, Lublin FD, Weinstock-Guttman B, Wynn DR, Lynn F, Panzara MA, Sandrock AW, SENTINEL Investigators (2006) Natalizumab plus interferon beta-1a for relapsing multiple sclerosis. N Engl J Med 354:911","journal-title":"N Engl J Med"},{"key":"268_CR27","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.22107","volume":"68","author":"RA Rudick","year":"2010","unstructured":"Rudick RA, O'Connor PW, Polman CH, Rudick RA, O'Connor PW, Polman CH (2010) Assessment of JC virus DNA in blood and urine from natalizumab-treated patients. Ann Neurol 68:304\u2013310","journal-title":"Ann Neurol"},{"key":"268_CR28","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s00415-009-5444-4","volume":"257","author":"SA Sadiq","year":"2010","unstructured":"Sadiq SA, Puccio LM, Brydon EW (2010) JCV detection in multiple sclerosis patients treated with natalizumab. J Neurol 257:954\u2013958","journal-title":"J Neurol"},{"key":"268_CR29","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/ana.410310426","volume":"31","author":"C Tornatore","year":"1992","unstructured":"Tornatore C, Berger JR, Houff SA, Curfman B, Meyers K, Winfield D, Major EO (1992) Detection of JC virus DNA in peripheral lymphocytes from patients with and without progressive multifocal leukoencephalopathy. Ann Neurol 31:454\u2013462","journal-title":"Ann Neurol"},{"key":"268_CR30","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/WNL.0b013e3182583022","volume":"78","author":"AK Trampe","year":"2012","unstructured":"Trampe AK, Hemmelmann C, Stroet A, Haghikia A, Hellwig K, Wiendl H, Goelz S, Ziegler A, Gold R, Chan A (2012) Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort. Neurology 78:1736\u20131742","journal-title":"Neurology"},{"key":"268_CR31","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/jcp.21937","volume":"222","author":"S Tremolada","year":"2010","unstructured":"Tremolada S, Delbue S, Castagnoli L, Allegrini S, Miglio U, Boldorini R, Elia F, Gordon J, Ferrante P (2010) Mutations in the external loops of BK virus VP1 and urine viral load in renal transplant recipients. J Cell Phisiol 222:195\u2013199","journal-title":"J Cell Phisiol"},{"key":"268_CR32","unstructured":"TYSABRI Safety Update. (2014) (Accessed January, 2014, at https:\/\/medinfo.biogenidec.com\/medinfo\/secure\/pmlresource.do?resource=TYSABRIPMLSafetyUpdate )"},{"key":"268_CR33","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/ana.22305","volume":"69","author":"C Warnke","year":"2011","unstructured":"Warnke C, Adams O, Hartung HP, Kieseier BC (2011) Assessment of JC virus DNA in blood and urine from natalizumab-treated patients. Ann Neurol 69:215\u2013216","journal-title":"Ann Neurol"}],"container-title":["Journal of NeuroVirology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-014-0268-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13365-014-0268-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-014-0268-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T16:08:31Z","timestamp":1559491711000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13365-014-0268-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,23]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["268"],"URL":"https:\/\/doi.org\/10.1007\/s13365-014-0268-0","relation":{},"ISSN":["1355-0284","1538-2443"],"issn-type":[{"value":"1355-0284","type":"print"},{"value":"1538-2443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,23]]}}}